2Xideas AG reduced its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 14.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 172,653 shares of the company’s stock after selling 29,166 shares during the quarter. Ryan Specialty accounts for 2.1% of 2Xideas AG’s holdings, making the stock its 11th largest position. 2Xideas AG owned approximately 0.07% of Ryan Specialty worth $9,731,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently bought and sold shares of RYAN. Ameritas Investment Partners Inc. boosted its stake in shares of Ryan Specialty by 0.9% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 21,119 shares of the company’s stock worth $1,190,000 after acquiring an additional 185 shares in the last quarter. MAI Capital Management grew its holdings in Ryan Specialty by 65.3% in the second quarter. MAI Capital Management now owns 476 shares of the company’s stock valued at $32,000 after purchasing an additional 188 shares during the period. Baker Tilly Wealth Management LLC increased its position in shares of Ryan Specialty by 5.6% in the third quarter. Baker Tilly Wealth Management LLC now owns 3,595 shares of the company’s stock valued at $203,000 after buying an additional 192 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Ryan Specialty by 5.2% during the 2nd quarter. ProShare Advisors LLC now owns 4,772 shares of the company’s stock worth $324,000 after buying an additional 238 shares during the period. Finally, Securian Asset Management Inc. raised its stake in shares of Ryan Specialty by 2.9% during the 3rd quarter. Securian Asset Management Inc. now owns 8,438 shares of the company’s stock worth $476,000 after buying an additional 241 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.
Ryan Specialty Stock Down 0.0%
RYAN stock opened at $36.16 on Friday. Ryan Specialty Holdings Inc. has a 52 week low of $35.84 and a 52 week high of $77.16. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. The company has a market cap of $9.55 billion, a P/E ratio of 86.11, a P/E/G ratio of 0.94 and a beta of 0.65. The company’s 50-day moving average price is $44.67 and its 200 day moving average price is $51.20.
Ryan Specialty Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 24th were issued a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.4%. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date was Tuesday, February 24th. Ryan Specialty’s payout ratio is presently 123.81%.
Insider Activity at Ryan Specialty
In related news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the company’s stock in a transaction dated Monday, February 23rd. The stock was bought at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the purchase, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. The trade was a 6.33% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 52.21% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
RYAN has been the subject of a number of research analyst reports. Keefe, Bruyette & Woods reduced their price objective on shares of Ryan Specialty from $65.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, February 13th. BMO Capital Markets cut Ryan Specialty from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $66.00 to $43.00 in a research report on Wednesday, February 25th. Morgan Stanley reduced their price objective on Ryan Specialty from $61.00 to $55.00 and set an “overweight” rating for the company in a research note on Monday, February 23rd. Barclays lowered their target price on shares of Ryan Specialty from $52.00 to $45.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Weiss Ratings lowered shares of Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, Ryan Specialty has an average rating of “Hold” and a consensus price target of $56.40.
Read Our Latest Stock Report on Ryan Specialty
Ryan Specialty Company Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
See Also
- Five stocks we like better than Ryan Specialty
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- This coin has everything going for it
- Only 500 people today…
- The gold chart Wall Street is terrified of…
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
